Cover Image
市場調查報告書

不孕治療的全球市場:2016∼2020年

Global Fertility Services Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 356726
出版日期 內容資訊 英文 93 Pages
訂單完成後即時交付
價格
Back to Top
不孕治療的全球市場:2016∼2020年 Global Fertility Services Market 2016-2020
出版日期: 2016年04月11日 內容資訊: 英文 93 Pages
簡介

全球不孕治療市場,預計2016∼2020年,以年複合成長率8.72%擴大。女性或男性的不孕為原因佔整體3分之一,而其他有不明或男女雙方原因。診斷不孕的原因很困難,不過,有不孕煩惱的人可依各種問題選擇各樣的治療方法。

本報告提供全球不孕治療市場現狀與至2020年的成長預測,市場趨勢與課題,各地區趨勢,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

  • 市場焦點
  • 不孕:概要
  • 流行病學
  • 症狀
  • 檢驗和診斷
  • 治療

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 不孕治療的階段

第7章 不孕治療,對體外受精的法律制度

第8章 不孕治療旅遊觀光事業

第9章 成本分析

第10章 各治療市場區隔

第11章 各地區市場市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第12章 主要國家

  • 美國
  • 英國
  • 比利時
  • 中國
  • 印度
  • 以色列

第13章 推動市場的要素

第14章 促進要素的影響

第15章 市場課題

第16章 促進要素與課題的影響

第17章 市場趨勢

  • 研究開發的促進
  • 新的不孕治療診所的成立
  • M&A和聯合的增加
  • 民眾的認識與政府的輔助
  • 醫療觀光

第18章 供應商環境

  • 競爭模式
  • 主要消息
  • 合併、收購
  • 專利及聯合
  • 主要供應商分析:2015年
  • 其他值得注意的供應商

第19章 附錄

圖表

目錄
Product Code: IRTNTR8280

About Fertility Services

Couples with fertility issues are unable to conceive even after regular unprotected coitus. Infertility complications are widespread, with either female or male infertility factors accounting for one-third of the cases. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. Low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm are some of the factors that can lead to infertility in males. Hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities are factors that can lead to infertility in women. Diagnosing the cause of infertility can be difficult, but people with fertility issues can choose from a variety of treatment options, depending on the underlying problem.

Technavio's analysts forecast the global fertility services market to grow at a CAGR of 8.72% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global fertility services market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of infertility drugs and assisted reproductive technology (ART).

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Fertility Services Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Carefertility
  • Coopersurgical
  • Ferring Pharmaceuticals
  • Merck
  • MonashIVF
  • Vitrolife

Other Prominent Vendors

  • Abbott Laboratories
  • AbbVie
  • Actavis
  • Apricus Biosciences
  • AstraZeneca
  • Auxogyn
  • Bristol-Myers Squibb
  • Cell Cura
  • Dong-A Socio
  • Elelixis Diagnostics
  • Eli Lilly
  • EMD Serono
  • Fertility Focus
  • Halotech
  • HRA Pharma
  • IKS International
  • In Vitro Care
  • Invo Bioscience
  • Irvine Scientific
  • IVFtech Aps
  • Kitazato
  • Life Global
  • Medical Electronic Systems
  • Meditex
  • Microtech IVF
  • Nidacon International
  • Novartis
  • NuSep
  • Ovascience
  • Pantec Biosolutions
  • Pfizer
  • PregLem
  • Reproductive Health Science
  • ReproTech
  • Sanofi
  • Smiths Medical International
  • Sperm Processor
  • Vitrolife
  • Vivus
  • Xytex Cryo International.

Market driver

  • Increase in infertility rate and obesity
  • For a full, detailed list, view our report

Market challenge

  • High cost of fertility treatment
  • For a full, detailed list, view our report

Market trend

  • Increase in R&D
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Infertility: An overview
  • Epidemiology
  • Signs and symptoms
  • Tests and diagnosis
  • Treatments

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Stages of fertility treatment

PART 07: Regulatory landscape of ART and IVF

  • Reporting requirements
  • Regulations governing IVF
  • Need for more guidelines and regulations

PART 08: Fertility tourism

PART 09: Cost analysis

  • Direct costs
  • Indirect costs
  • Cost of IVF treatments

PART 10: Market segmentation by type of treatment

  • Infertility drugs
  • Global infertility drugs market
  • ART
  • Global ART market

PART 11: Geographical segmentation

  • Fertility services market in Americas
  • Fertility services market in EMEA
  • Fertility services market in APAC

PART 12: Key leading countries

  • US
  • UK
  • Belgium
  • China
  • India
  • Israel

PART 13: Market drivers

  • Increase in infertility rate and obesity
  • Increase in success rate of infertility treatments
  • Growing demand for ART and acceptance of same-sex marriage in developed countries

PART 14: Impact of drivers

PART 15: Market challenges

  • High cost of fertility treatments
  • Complications related to fertility services
  • Ethical, legal, and social issues
  • Limited reimbursement

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Increase in R&D
  • Establishment of new fertility clinics
  • Increase in M&A and collaborations
  • Public awareness and government support
  • Medical tourism

PART 18: Vendor landscape

  • Competitive scenario
  • Key news
  • Mergers and acquisitions
  • Licenses and collaborations
  • Key vendor analysis 2015
  • Other prominent vendors

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Causes of male infertility
  • Exhibit 03: Etiologies of female infertility
  • Exhibit 04: Infertility in people aged 35 and above in US 2002 and 2010
  • Exhibit 05: Global fertility services market 2015-2020 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Stages of fertility treatment
  • Exhibit 08: Assessment of regulatory landscape
  • Exhibit 09: Fertility tourism: Major hotspots
  • Exhibit 10: Number of visitors to fertility clinics in medical tourism hotspots worldwide 2013-2015
  • Exhibit 11: Average cost of hormonal stimulation in IVF by age ($)
  • Exhibit 12: Cost analysis of IVF by various stages in US
  • Exhibit 13: Segmentation of global fertility services market by type of treatment
  • Exhibit 14: Segmentation of infertility drug usage by geography 2015
  • Exhibit 15: Global infertility drugs market 2015-2020 ($ billions)
  • Exhibit 16: Types of ART procedures
  • Exhibit 17: Segmentation based on adoption of ART procedures in US 2015
  • Exhibit 18: IVF procedure
  • Exhibit 19: Success rate of IVF
  • Exhibit 20: Segmentation based on adoption of ART by geography 2015
  • Exhibit 21: Global ART market 2015-2020 ($ billions)
  • Exhibit 22: Segmentation of global fertility services market by geography 2015
  • Exhibit 23: Fertility services market in Americas 2015-2020 ($ billions)
  • Exhibit 24: Number of ART cycles in Americas
  • Exhibit 25: Fertility services market in EMEA 2015-2020 ($ billions)
  • Exhibit 26: Number of ART cycles in EMEA
  • Exhibit 27: Fertility services market in APAC 2015-2020 ($ billions)
  • Exhibit 28: Number of ART cycles in APAC
  • Exhibit 29: Married women with primary infertility in US 1965-2010
  • Exhibit 30: Causes of infertility in UK 2009
  • Exhibit 31: Percentage of infertility among couples attempting pregnancy 2012
  • Exhibit 32: Population of women of reproductive age (20-44 years) in billions 2015
  • Exhibit 33: Segmentation of fertility rate among women by age 2014
  • Exhibit 34: Obesity-related fertility issues
  • Exhibit 35: Impact of drivers
  • Exhibit 36: Average cost of various fertility services worldwide
  • Exhibit 37: Reimbursement scenario in Americas
  • Exhibit 38: Reimbursement scenario in Europe
  • Exhibit 39: Reimbursement scenario in Asia
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Number of fertility clinics worldwide 2012
  • Exhibit 42: Recent M&A
  • Exhibit 43: Stakeholders involved in fertility services
  • Exhibit 44: Some trends in global fertility services market
  • Exhibit 45: CARE Fertility: Key takeaways
  • Exhibit 46: CooperSurgical: Business segmentation by revenue 2014
  • Exhibit 47: CooperSurgical: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 48: CooperSurgical: Key takeaways
  • Exhibit 49: Ferring Pharmaceuticals: Business segmentation
  • Exhibit 50: Ferring Pharmaceuticals: Key takeaways
  • Exhibit 51: Monash IVF: Business segmentation by revenue 2015
  • Exhibit 52: Monash IVF: Geographical segmentation by revenue 2015
  • Exhibit 53: Monash IVF: Key takeaways
  • Exhibit 54: Merck: Business segmentation by revenue 2014
  • Exhibit 55: Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 56: Merck: Geographical segmentation by revenue 2014
  • Exhibit 57: Merck: Key drivers in fertility services sector
  • Exhibit 58: Merck: Key takeaways
  • Exhibit 59: Vitrolife: Geographical segmentation by revenue 2014
  • Exhibit 60: Vitrolife: Key takeaways
  • Exhibit 61: Drug manufacturing companies
  • Exhibit 62: Equipment and media developing companies
  • Exhibit 63: Fertility service providers
Back to Top